PUBLISHER: Grand View Research | PRODUCT CODE: 1376133
PUBLISHER: Grand View Research | PRODUCT CODE: 1376133
The global particle size analysis market size is anticipated to reach USD 578.83 million by 2030, registering a CAGR of 5.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The industry is expected to experience growth due to increased research and development in nanotechnology, global adoption of nanotechnology, rising investments in pharmaceutical research, and the growing demand for analyzers across various end-use sectors. Particle size analysis is essential for quality control and assurance in industries like pharmaceuticals, food and beverages, and cosmetics. Ensuring product consistency and meeting regulatory requirements necessitates precise measurement of particle sizes.
In addition, the pharmaceutical and healthcare industries continually require particle size analysis for drug formulation, quality control, and research into drug delivery systems. As these industries expand, the demand for particle size analysis instruments is expected to grow over the forecast period. Nanotechnology applications often rely on precise control of particle sizes. As nanotechnology continues to advance, particle size analysis becomes increasingly important for characterizing and manufacturing nanomaterials. Moreover, monitoring air and water quality, as well as detecting and characterizing particulate matter, requires particle size analysis. Thus, the growing environmental regulations and concerns are anticipated to drive the market demand in the coming years.
Rapid industrialization and economic growth in emerging markets contribute to increased demand for particle size analysis instruments as various industries expand and modernize their processes. In addition, the ongoing technological advancements in the market, including automation, improved accuracy, and ease of use, make these tools more accessible and valuable to a broader range of industries. However, industries subject to strict regulatory standards, such as pharmaceuticals and environmental monitoring, require accurate particle size analysis to ensure compliance with regulations, which drives the market. In 2022, the market was characterized by the dominance of influential leaders, such as Horiba Ltd, Microtrac Inc., Malvern Panalytical Ltd., Beckman Coulter Inc., and Agilent Technologies Inc.
These key players held significant market shares, showcasing their robust positions in the industry. To address the increasing demands from various sectors, businesses are adopting strategies, such as M&As, setting up new manufacturing facilities, and expanding their geographic presence. For instance, in July 2023, Beckman Coulter introduced the DxI9000 Access Immunoassay Analyzer in North America, addressing the critical requirements of clinical laboratories for speed, reliability, reproducibility, quality, and scalability. With healthcare providers and pharmaceutical companies aiming to combat increasingly challenging diseases, the DxI9000 Analyzer has demonstrated its ability to produce assays with heightened sensitivity and clinically significant features, positioning it well to meet future testing demands.